# FDA Inspection 1176535 - Bernardo Leon Rapoport, M.D. - July 14, 2022

Source: https://www.keypedia.com/records/fda_inspections/bernardo-leon-rapoport-md/7da5a6fd-c54a-4be4-8652-54246d6e8f31
Source feed: FDA_Inspections

> FDA Inspection 1176535 for Bernardo Leon Rapoport, M.D. on July 14, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1176535
- Company Name: Bernardo Leon Rapoport, M.D.
- Inspection Date: 2022-07-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1300998 - 2026-01-29](https://www.keypedia.com/records/fda_inspections/bernardo-leon-rapoport-md/4d74b383-acc0-42ab-aace-37b289a465bd)
- [FDA Inspection 1300998 - 2026-01-29](https://www.keypedia.com/records/fda_inspections/bernardo-leon-rapoport-md/bd7985ec-ddee-491c-b29c-e9c7a5f70605)

Company: https://www.keypedia.com/companies/bernardo-leon-rapoport-md/b82110bd-bd6b-4e5a-be1f-15406e1d8e18

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c